Disease | myocardial infarction |
Symptom | C0018802|congestive heart failure |
Sentences | 17 |
PubMedID- 21199333 | Cardiovascular disease (cvd), especially myocardial infarction (mi) with resultant congestive heart failure (chf), is a leading cause of mortality and morbidity worldwide 1. |
PubMedID- 22357361 | Introduction and objectives: to compare acute myocardial infarction patients with or without congestive heart failure in the french fast-mi registry. |
PubMedID- 26209495 | Results: patients having cuf were more likely to have diabetes, vascular disease, chronic obstructive pulmonary disease, congestive heart failure, history of a myocardial infarction, or an intraaortic balloon pump (p < 0.05). |
PubMedID- 26005421 | The purpose of the allstar study (allogeneic heart stem cells to achieve myocardial regeneration) is to investigate the safety and efficacy of the treatment in decreasing infarct size, with the primary efficacy endpoint being the relative percentage improvement in infarct size as assessed using magnetic resonance imaging at 6 and 12 months post-infusion (allogeneic heart stem cells to achieve myocardial regeneration (allstar) (nct01458405)2. more recently, a phase i/ii randomized, double-blind, placebo controlled clinical trial was proposed by a european study group initiative (care-mi) to investigate the therapeutic role of allogeneic cscs in patients with congestive heart failure due to myocardial infarction (crisostomo et al., 2015). |
PubMedID- 20730062 | A meta-analysis of all randomized trials showed that amiodarone reduced total mortality by 10 to 19%.30 the risk reduction was similar in primary prevention after myocardial infarction or in patients with congestive heart failure (chf), and in secondary prevention after cardiac arrest.30 in a pooled database from 2 similar randomized clinical trials (the european amiodarone myocardial infarction trial (emiat) and the canadian amiodarone myocardial infarction trial (camiat)), that evaluated use of amiodarone in primary prevention in patients recovering from myocardial infarction, cardiac death and arrhythmic death or resuscitated cardiac arrest, were significantly lower in patients receiving amiodarone, compared to placebo (p = 0.05 and 0.03, respectively), if they were also receiving beta-blockers.31 there appeared to be no benefit of amiodarone over placebo in patients not receiving beta-blockers. |
PubMedID- 22549451 | congestive heart failure due to myocardial infarction (mi) was induced by the coronary artery ligation in rats. |
PubMedID- 22293888 | recently observed that ms predicted congestive heart failure independent of interim myocardial infarction in elderly finns . |
PubMedID- 23133676 | Based on our results we assume that the reported increased mortality is rather a consequence of the concomitant heart disease than the conduction delay in itself as β-ar blockade basically shows positive effects on mortality in patients after myocardial infarction or in patients with congestive heart failure , . |
PubMedID- 22474044 | Postmortem examination revealed coronary arteriosclerosis and myocardial infarction leading to congestive heart failure. |
PubMedID- 19949891 | This study investigated whether improvement in cardiac function and attenuation of cardiac remodeling by some beta-adrenoceptor (beta-ar) antagonists were associated with a depression in sympathetic activity in congestive heart failure (chf) due to myocardial infarction (mi). |
PubMedID- 21755036 | This concept is reinforced by the beneficial effects of carvedilol for the reduction in morbidity and mortality in patients after myocardial infarction and with systolic congestive heart failure . |
PubMedID- 24876877 | A new born infant whose mother ingested an herbal medication, blue cohosh, to promote uterine contractions presented with acute myocardial infarction associated with profound congestive heart failure and shock 7. |
PubMedID- 21828948 | Relationship between plasma homocysteine levels and congestive heart failure in patients with acute myocardial infarction. |
PubMedID- 21545710 | Background: progressive remodeling of the left ventricle (lv) following myocardial infarction (mi) can lead to congestive heart failure, but the underlying initiation factors remain poorly defined. |
PubMedID- 25790351 | This is in disagreement with one study showing upregulation of lactate transporter (mct1) and increased rate of lactate uptake in a rat model of congestive heart failure due to myocardial infarction . |
PubMedID- 19945701 | Objective: we investigated whether the metabolic syndrome (mets) and its components defined by four different criteria including subjects with prevalent diabetes in their definitions were associated with congestive heart failure (chf) independent of interim myocardial infarction (mi) and prevalent diabetes during a 20-year follow-up in an elderly population-based study. |
PubMedID- 22004043 | myocardial infarction (mi) with resultant congestive heart failure (chf) is a leading cause of mortality and morbidity in developed countries. |
Page: 1